Hypoxia-inducible factor-1 gene polymorphisms and cancer risk: A meta-analysis

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Zhao, Tongfeng ^a   Lv, Jing ^a   Zhao, Jiangpei ^b   Nzekebaloudou, Marius ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Hangzhou Hospital of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER RISK; CAUCASIAN; CLINICAL TRIAL; DNA POLYMORPHISM; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; SEX DIFFERENCE; SYSTEMATIC REVIEW; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; NEOPLASM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 76249131253     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-159     Document Type: Article

References (29)

1. Cancer statistics, 2009. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun, CA Cancer J Clin 2009 59 4 225 249 19474385 10.3322/caac.20006
2. Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk. ME Wright U Peters MJ Gunter SC Moore KA Lawson M Yeager SJ Weinstein K Snyder J Virtamo D Albanes, Cancer Res 2009 69 4 1429 1438 19190344 10.1158/0008-5472.CAN-08-2343
3. Genetic variations in esophageal cancer risk and prognosis. WY Cheung G Liu, Gastroenterol Clin North Am 2009 38 1 75 91 19327568 10.1016/j.gtc.2009.01. 009
4. Cancer stem cells, hypoxia and metastasis. RP Hill DT Marie-Egyptienne DW Hedley, Semin Radiat Oncol 2009 19 2 106 111 19249648 10.1016/j.semradonc.2008. 12.002
5. Clinical implications of hypoxia inducible factor in renal cell carcinoma. MC Smaldone JK Maranchie, Urol Oncol 2009 27 3 238 245 19414111
6. Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. K Tanimoto K Yoshiga H Eguchi M Kaneyasu K Ukon T Kumazaki N Oue W Yasui K Imai K Nakachi L Poellinger M Nishiyama, Carcinogenesis 2003 24 1779 1783 10.1093/carcin/bgg132 12919954
7. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. H Zhong AM De Marzo E Laughner M Lim DA Hilton D Zagzag, Cancer Res 1999 59 5830 5835 10582706
8. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer. MF Munoz-Guerra ME Fernandez-Contreras AL Moreno ID Martin B Herraez C Gamallo, Ann Surg Oncol 2009 16 8 2351 2358 19449077 10.1245/s10434-009-0503-8
9. The HIF-1 C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers. R Foley L Marignol AZ Thomas IM Cullen AS Perry P Tewari A O'Grady E Kay B Dunne B Loftus WR Watson JM Fitzpatrick K Woodson T Lehman D Hollywood TH Lynch M Lawler, Cancer Biol Ther 2009 8 2 118 124 19106642
10. Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer. H Li GJ Bubley SP Balk JM Gaziano M Pollak MJ Stampfer J Ma, Prostate 2007 67 12 1354 1361 17624927 10.1002/pros.20589 (Pubitemid 47435783)
11. The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancer. A Orr-Urtreger A Bar-Shira H Matzkin NJ Mabjeesh, Prostate 2007 67 1 8 13 16998808 10.1002/pros.20433 (Pubitemid 46013462)
12. Polymorphism in the hypoxia-inducible factor 1 alpha gene may confer susceptibility to androgen-independent prostate cancer. CH Chau MG Permenter SM Steinberg AS Retter WL Dahut DK Price WD Figg, Cancer Biol Ther 2005 4 11 1222 1225 16205110
13. Rare variant of hypoxia-inducible factor-1alpha (HIF-1A) and breast cancer risk in Korean women. JY Lee JY Choi KM Lee SK Park SH Han DY Noh SH Ahn DH Kim YC Hong E Ha KY Yoo CB Ambrosone D Kang, Clin Chim Acta 2008 389 1-2 167 170 18160046 10.1016/j.cca.2007.12.005
14. Single nucleotide polymorphisms in the hypoxia-inducible factor-1alpha (HIF-1alpha) gene in human sporadic breast cancer. I Apaydin E Konac HI Onen M Akbaba E Tekin A Ekmekci, Arch Med Res 2008 39 3 338 345 18279708 10.1016/j.arcmed.2007.11.012 (Pubitemid 351227407)
15. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer. HO Kim YH Jo J Lee SS Lee KS Yoon, Oncol Rep 2008 20 5 1181 1187 18949419
16. HIF-1A gene mutations associated with higher microvessel density in endometrial carcinomas. N Horree AJ Groot WA Van Hattem AP Heintz M Vooijs PJ Van Diest, Histopathology 2008 52 5 637 639 18370960 10.1111/j.1365-2559.2008. 02991.x
17. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers. E Konac HI Onen J Metindir E Alp AA Biri A Ekmekci, Cancer Detect Prev 2007 31 2 102 109 17418979 10.1016/j.cdp.2007.01.001 (Pubitemid 46680371)
18. Association between ulcerative growth and hypoxia inducible factor-1 alpha polymorphisms in colorectal cancer patients. K Fransen M Fenech M Fredrikson C Dabrosin P Soderkvist, Mol Carcinog 2006 45 11 833 840 16865676 10.1002/mc.20209 (Pubitemid 44646335)
19. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. T Kuwai Y Kitadai S Tanaka T Kuroda T Ochiumi S Matsumura N Oue W Yasui M Kaneyasu K Tanimoto M Nishiyama K Chayama, Oncol Rep 2004 12 5 1033 1037 15492789
20. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. M Ollerenshaw T Page J Hammonds A Demaine, Cancer Genet Cytogenet 2004 153 2 122 126 15350301 10.1016/j.cancergencyto.2004.01.014 (Pubitemid 39592144)
21. The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1 in renal cell carcinoma. SC Clifford D Astuti L Hooper PH Maxwell PJ Ratcliffe ER Maher, Oncogene 2001 20 5067 5074 10.1038/sj.onc.1204602 11526493
22. Common single nucleotide polymorphism of hypoxia-inducible factor-1 alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma. TS Ling RH Shi GX Zhang H Zhu LZ Yu XF Ding, Chin J Dig Dis 2005 6 4 155 158 16246222 10.1111/j.1443-9573.2005.00223.x (Pubitemid 43918439)
23. A method for meta-analysis of molecular association studies. A Thakkinstian P McElduff C D'Este D Duffy J Attia, Stat Med 2005 24 9 1291 1306 15568190 10.1002/sim.2010 (Pubitemid 40585169)
24. Bias in meta-analysis detected by a simples, graphical test. M Egger G Davey Smith M Schneider C Minder, BMJ 1997 315 629 634 9310563
25. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. L Bax LM Yu N Ikeda H Tsuruta KGM Moons, BMC Med Res Methodol 2006 6 50 10.1186/1471-2288-6-50 17038197
26. MIX: comprehensive free software for meta-analysis of causal research data. Version 1.7. L Bax LM Yu N Ikeda H Tsuruta KGM Moons, 2008 http://mix-for-meta-analysis.info
27. Association of uteroglobin G38A polymorphism with IgA nephropathy: a meta-analysis. D Yong W QingQing L Hua, Am J Kidney Dis 2006 48 1 1 7 16797381 10.1053/j.ajkd.2006.03.048
28. Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. AA Kazi JM Jones RD Koos, Mol Endocrinol 2005 19 8 2006 2019 15774498 10.1210/me.2004-0388 (Pubitemid 41130691)
29. Estrogen and progestin regulate HIF-1alpha expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway. K Hua J Din Q Cao W Feng Y Zhang L Yao Y Huang Y Zhao Y Feng, Oncol Rep 2009 21 4 893 898 19287985